Clinical trials recruiting for Refractory Lupus Nephritis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CD19-BCMA CAR-T cells infusion | 1 |
| KYV-101 | 1 |
| NK 010 or NK042 | 1 |
| Rituximab | 1 |
| umbilical cord blood CD19-BCMA CAR-T cells infusion | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Colorado | 1 |
Top cities
Self-screener
Recruiting trials
- A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
- NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
- Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Related conditions
Trials recruiting for Refractory Lupus Nephritis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Refractory Lupus Nephritis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.